Should Emerging Managers Chase HNWs?

As GP-led secondaries scale to record levels, top investors are flagging a widening gap between trophy assets and weaker deals, even as new financing tools like CFOs further blur the line between sale and securitization.

Riverpoint Medical is a developer and manufacturer of minimally invasive surgical consumables.

Sponsors who spent years building AI infrastructure exposure are now using continuation vehicles to avoid selling what they believe is still appreciating.